A phase II study of alemtuzumab, fludarabine, cyclophosphamide, and doxorubicin (Campath-FCD) in peripheral T-cell lymphomas
Article
Weidmann, Eckhart, Hess, Georg, Chow, Kai U., Krause, Stefan W.
, Subklewe, Marion, Kruse, Judith, Weisel, Katja C., Soekler, Martin, Kim, Soo-Zin, Napieralski, Simone, Rech, Jürgen, Dreyling, Martin, Jäger, Elke and Mitrou, Paris S.
(2010)
A phase II study of alemtuzumab, fludarabine, cyclophosphamide, and doxorubicin (Campath-FCD) in peripheral T-cell lymphomas.
Leukemia & Lymphoma 51 (3), pp. 447-455.
Alternative links to fulltext
Involved Institutions
Details
| Item type | Article | ||||
| Journal or Publication Title | Leukemia & Lymphoma | ||||
| Publisher | TAYLOR & FRANCIS LTD | ||||
| Place of Publication | ABINGDON | ||||
| Volume | 51 | ||||
| Number of Issue or Book Chapter | 3 | ||||
| Page Range | pp. 447-455 | ||||
| Date | 2010 | ||||
| Date of publication | 19 Dec 2024 11:39 | ||||
| Institutions | Medicine > Lehrstuhl für Innere Medizin III (Hämatologie und Internistische Onkologie) | ||||
| Identification Number |
| ||||
| Keywords | CHRONIC LYMPHOCYTIC-LEUKEMIA; MYCOSIS FUNGOIDES/SEZARY-SYNDROME; ANTI-CD52 MONOCLONAL-ANTIBODY; NON-HODGKINS-LYMPHOMAS; CARDIAC TOXICITY; CHEMOTHERAPY; COMBINATION; THERAPY; MANAGEMENT; TRIAL; Alemtuzumab; fludarabine; peripheral T-cell lymphoma (PTCL) | ||||
| Dewey Decimal Classification | 600 Technology > 610 Medical sciences Medicine | ||||
| Status | Published | ||||
| Refereed | Yes, this version has been refereed | ||||
| Created at the University of Regensburg | Yes | ||||
| Item ID | 66348 |
Export bibliographical data
Owner only: item control page
Altmetric
Altmetric